Stockscreener 앱 받기
324.34
0.45%
-1.46
시간 외 거래:
324.34
전일 마감가:
$325.80
열려 있는:
$324.77
하루 거래량:
328.72K
Relative Volume:
0.54
시가총액:
$22.83B
수익:
$2.36B
순이익/손실:
$236.10M
주가수익비율:
98.70
EPS:
3.286
순현금흐름:
$382.50M
1주 성능:
-1.41%
1개월 성능:
+1.99%
6개월 성능:
+24.98%
1년 성능:
+38.98%
1일 변동 폭
$321.66
$326.81
1주일 범위
$320.75
$335.26
52주 변동 폭
$227.03
$353.50
인슐렛 코퍼레이션 Stock (PODD) Company Profile
명칭
Insulet Corporation
전화
978-600-7000
주소
100 NAGOG PARK, ACTON, MA
PODD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
324.34 | 22.93B | 2.36B | 236.10M | 382.50M | 3.286 |
|
ABT
Abbott Laboratories
|
126.61 | 221.35B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
100.97 | 151.78B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
375.93 | 146.70B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
93.23 | 120.73B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.19 | 47.45B | 5.69B | 1.41B | 577.90M | 6.9828 |
인슐렛 코퍼레이션 Stock (PODD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 재개 | Oppenheimer | Outperform |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-05-13 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | 개시 | RBC Capital Mkts | Outperform |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-07 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-21 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-08-21 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-02-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-07-28 | 개시 | Wells Fargo | Overweight |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 개시 | BofA/Merrill | Neutral |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-12-10 | 개시 | CFRA | Sell |
| 2019-10-23 | 개시 | Stifel | Hold |
| 2019-10-18 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-10-04 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-10-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-06 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-06-10 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-04-20 | 개시 | Berenberg | Buy |
| 2018-02-22 | 재확인 | Barclays | Overweight |
| 2018-01-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 개시 | Barclays | Overweight |
모두보기
인슐렛 코퍼레이션 주식(PODD)의 최신 뉴스
Why Insulet Corporation (GOV) stock stays resilientJobs Report & Weekly Momentum Stock Picks - newser.com
United States Insulin Pump Market Outlook and Company Analysis Report 2025-2033 Featuring Medtronic, Insulet, Tandem Diabetes Care, Roche, Ypsomed, Microtech Medical - Yahoo! Finance UK
Advanced analytics toolkit walkthrough for Insulet CorporationQuarterly Market Summary & Safe Capital Allocation Plans - newser.com
Sector ETF performance correlation with Insulet CorporationGlobal Markets & Risk Adjusted Swing Trade Ideas - newser.com
Multi asset correlation models including Insulet CorporationMarket Movement Recap & Long-Term Investment Growth Plans - newser.com
Full technical analysis of Insulet Corporation stockEarnings Trend Report & Daily Technical Stock Forecast Reports - newser.com
Why Insulet Corporation (GOV) stock could outperform next yearWeekly Market Report & Reliable Price Breakout Alerts - newser.com
Will Insulet Corporation stock deliver strong dividend growth2025 Earnings Impact & Expert Approved Momentum Trade Ideas - newser.com
Is Insulet Corporation stock a buy before product launchesJuly 2025 Action & Daily Profit Focused Stock Screening - newser.com
Can Insulet Corporation stock sustain revenue growthTrade Signal Summary & Safe Entry Momentum Stock Tips - newser.com
Why Insulet Corporation (GOV) stock could break out in 2025Profit Target & Accurate Intraday Trading Signals - newser.com
How to monitor Insulet Corporation with trend dashboardsJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Insulet’s New Study on Simplified Onboarding for Type 2 Diabetes Management: A Potential Game Changer - TipRanks
Will Insulet Corporation outperform the marketWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - newser.com
Insulet’s Omnipod 5 Study: A Real-World Evaluation of Diabetes Management - TipRanks
Insulet’s Omnipod 5 SA2.0 Study: A Leap in Diabetes Management - TipRanks
How to interpret RSI for Insulet Corporation stock2025 Technical Overview & Reliable Breakout Forecasts - newser.com
Why Insulet Corporation stock could outperform in 20252025 Bull vs Bear & Daily Volume Surge Signals - newser.com
Why Insulet Corporation stock appeals to dividend seekersJuly 2025 Weekly Recap & Reliable Volume Spike Trade Alerts - newser.com
인슐렛 코퍼레이션 (PODD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.12%
5.50%
자본화:
|
볼륨(24시간):